List of Board Members
As of July 1, 2026
| Chairperson | Miyabashira Asuka（President. Japan Pharma Business Unit, Takeda Pharmaceutical Co., Ltd.） |
|---|---|
| Vice President | Osamu Okuda, Ph.D.（Representative Director, President, Chugai Pharmaceutical Co., Ltd.）
Yasukawa Kenji, Ph.D.（Representative Director, Chairman of the Board, Astellas Pharma Inc.） Naito Keisuke（Representative Corporate Officer, Executive Vice President COO, Eisai Co., Ltd.） Teshirogi Isao, Ph.D.（Representative Director, President and CEO, Shionogi & Co., Ltd.） Kimura Toru, Ph.D.（Representative Director, President and CEO, Sumitomo Pharma Co., Ltd.） Manabe Sunao, Ph.D.（Executive Chairperson, Daiichi Sankyo Co., Ltd.） |
| Standing Director | Andy Barnett（Representative Director and President, AstraZeneca K.K.）
Hiromichi Shirasawa, MD（Chairman and Representative Director Head of Japan Development, MSD Co., Ltd.） Matsuo Yoshirou（Vice President and Representative Director, Otsuka Pharmaceutical Co., Ltd.） Miyazawa Keiji, Ph.D.（Representative Director, President and COO, Kissei Pharmaceutical Co., Ltd.） Miyamoto Masashi, Ph.D.（Chief Executive Officer（CEO）and Region President, JPAC, Kyowa Kirin Co., Ltd.） Paul Lirette（President & Representative Director, GlaxoSmithKline K.K.） Keiko Tone（Acting Country Lead / General Manager, General Medicines Japan, Sanofi K.K） Harada Akihisa（Chief Executive Officer, Tanabe Pharma Corporation） Igarashi Hiroo（President & Representative Director, Pfizer Japan Inc.） |
| Directors | Aoki Yoshikazu, Ph.D.（President & CEO, Asahi Kasei Therapeutics Corporation）
Horiuchi Hiroyuki（President and Representative Director, Kaken Pharmaceutical Co., Ltd） Ogihara Yutaka（Representative Director, President and Chief Executive Officer, Kyorin Pharmaceutical Co., Ltd.） Miwa Yoshihiro（Chairman, Executive Director, President & C.E.O., Kowa Co., Ltd.） Ito Takeshi（President, Chief Executive Officer, Santen Pharmaceutical Co., Ltd.） Uehara Shigeru（Chief Executive Officer, Taisho Pharmaceutical Co., Ltd.） Kobayashi Masayuki（President, Taiho Pharmaceutical Co., Ltd.） Taneda Masaki（President, Teijin Pharma Limited） Kondo Nobumasa（Representative Director, President and Chief Executive Officer, Torii Pharmaceutical Co., Ltd.） Karla AIcazar（President, Eli Lilly Japan K.K.） Toru Nakai (President, NIPPON SHINYAKU Co., Ltd.) Masataka Ogimura (President, Pharmaceutical Business Unit, NIPPON BOEHRINGER INGELHEIM CO., LTD.) John Paul Pullicino (President, NOVARTIS PHARMA K.K.) Ashraf Al-Ouf (President, BAYER YAKUHIN, LTD.) Kazuhide Nakatomi (President, Hisamitsu Pharmaceutical Co.,Inc.) Hidehito Katsuma (President, Bristol-Myers Squibb K.K.) Daikichiro Kobayashi (Chairman, Meiji Seika Pharma Co., Ltd.) Naoyuki Mochida (President, MOCHIDA PHARMACEUTICAL CO., LTD.) Christopher Rieger (President, JANSSEN PHARMACEUTICAL K.K.) |
| Auditors | Yamaguchi Sohta（President, ASKA Pharmaceutical Co., Ltd.）
Ibe Mitsuhiro（President and COO, Zeria Pharmaceutical Co., Ltd.） |
| Director General | Kenshi Kinoshita |
| Senior Managing Director | Yasunori Yoshida |
| Managing Director | Yoshiyuki Ishida
Go Takahashi |